Health
Clinical Breakthrough: ANVISA Approves Human Trials for Spinal Cord Repair
In February 2026, ANVISA authorized the first phase of human clinical trials for a revolutionary spinal cord regeneration method led by…
49
In February 2026, ANVISA authorized the first phase of human clinical trials for a revolutionary spinal cord regeneration method led by…